January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
Neuren Pharmaceuticals, Ltd
Neuren Pharmaceuticals (ASX: NEU) is developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options.